Health
New drug candidate to fight COVID-19 – Goondiwindi Argus
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.
Its…
-
General19 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General23 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
General6 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General10 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals